增强思维在运动®作为一个虚拟的程序交付模式,为那些生活在痴呆症和他们的护理合作伙伴的人
Bobby Neudorf1, Christopher Dinh1, Vanessa Barnes2
1Department of Kinesiology, University of Waterloo, Waterloo, Ontario, Canada.
PloS one
|January 19, 2024
概括
虚拟的"心灵在运动中"计划有效地增强了痴呆症患者及其护理伙伴的身体和认知活动. 这种安全和可访问的程序显著改善了生活质量和参与身体和认知活动.
科学领域:
- 老年学是一门学科.
- 痴呆症护理 痴呆症护理 痴呆症护理
- 公共卫生 公共卫生
背景情况:
- 安大略省阿尔茨海默病学会的"心灵在运动中" (MiM) 计划提高了痴呆症 (PLWD) 患者及其护理伙伴 (CP) 的身体功能和福祉.
- 由于COVID-19大流行,MIM计划需要快速过渡到虚拟格式,以确保安全性和有效性.
研究的目的:
- 描述一个标准化的虚拟MiM程序的设计.
- 评估虚拟MiM程序对生活质量,以及PLWD和CP的身体和认知活动水平的可接受性,安全性和影响.
主要方法:
- 采用混合方法方法,通过文献审查和对现有虚拟实践的调查进行了调查.
- 标准化的虚拟MiM程序包括每周8次90分钟的会议,包括45分钟的体育活动和45分钟的认知刺激.
- 参与者 (111名PLWD和90名CP) 完成了计划前和后的评估,衡量了生活质量,身体和认知活动以及计划满意度.
主要成果:
- 在虚拟程序期间没有报告任何不良事件.
- 参与者对该计划的评价很高 (平均得分为4.5/5).
- 观察到PLWD (p < 0.01) 的生活质量显著改善,以及PLWD和CP的身体活动 (p < 0.01) 和认知活动 (p < 0.01) 水平增加.
结论:
- 标准化的虚拟MiM程序是一种可接受,安全和有效的干预.
- 该计划成功地改善了痴呆症患者及其护理伙伴的生活质量,体力活动和认知活动.
- 虚拟交付提供了一种可行的和有益的方法,以保持在痴呆症护理计划中的参与和幸福感.
相关概念视频
Cognitive Development During Adulthood
112
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
112
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
Intellectual Disability
55
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
55
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
Learning Disabilities
147
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
Dyslexia
Dyslexia is a...
147
Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490


